TISA-118

N/A

Report date: 2025/10/23 17:54:16
NME

Base Information

Drug NameTISA-118
Drug Alias NameTISA-118
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEuropeMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAitiya (Shanghai) Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAitiya (Shanghai) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, AdultIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic Obstructive +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A